JP Morgan Chase’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99M Buy
229,268
+58,759
+34% +$806K ﹤0.01% 3779
2025
Q4
$2.35M Sell
170,509
-38,674
-18% -$910K ﹤0.01% 3959
2025
Q3
$5.11M Sell
209,183
-38,241
-15% -$931K ﹤0.01% 3342
2025
Q2
$5.72M Buy
247,424
+112,116
+83% +$2.95M ﹤0.01% 3026
2025
Q1
$3.65M Sell
135,308
-56,295
-29% -$2.12M ﹤0.01% 3416
2024
Q4
$10.3M Buy
191,603
+173,211
+942% +$9.16M ﹤0.01% 2667
2024
Q3
$836K Sell
18,392
-821
-4% -$35.7K ﹤0.01% 4583
2024
Q2
$805K Sell
19,213
-130
-0.7% -$6.1K ﹤0.01% 4409
2024
Q1
$728K Buy
19,343
+1,607
+9% +$35K ﹤0.01% 4553
2023
Q4
$190K Sell
17,736
-130,873
-88% -$1.13M ﹤0.01% 5410
2023
Q3
$1.5M Sell
148,609
-4,827
-3% -$55.7K ﹤0.01% 3780
2023
Q2
$1.82M Buy
153,436
+23,779
+18% +$318K ﹤0.01% 3605
2023
Q1
$1.57M Buy
129,657
+25,874
+25% +$431K ﹤0.01% 3709
2022
Q4
$1.37M Sell
103,783
-1,270
-1% -$18.6K ﹤0.01% 3850
2022
Q3
$1.42M Buy
105,053
+1,575
+2% +$21K ﹤0.01% 3747
2022
Q2
$1.26M Buy
103,478
+85,552
+477% +$1.01M ﹤0.01% 3907
2022
Q1
$256K Buy
17,926
+4,638
+35% +$75.9K ﹤0.01% 5060
2021
Q4
$262K Buy
13,288
+6,814
+105% +$143K ﹤0.01% 5200
2021
Q3
$140K Buy
6,474
+5,828
+902% +$168K ﹤0.01% 5403
2021
Q2
$16K Buy
+646
New +$14.4K ﹤0.01% 5969

Other funds holding JANX